Merck strikes $3.5B collab with local RNA startup, invests in $221M Series B
Pharma giant Merck& Co. will partner with local startup Orna Therapeutics on multiple vaccines and treatments for infectious diseases and cancer.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Health Management | Infectious Diseases | Merck | Pharmaceuticals | Vaccines